PORCUPINE highlighted genes and TFs that are enriched in driving heterogeneity among leiomyosarcoma patients, including RB1 and PPP2R1A as target genes, as well as the TFs E2F8 and ZNF282, which could potentially be inhibited (55). This evidence concerns the gene RB1 and leiomyosarcoma.